questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Traitements médicamenteux de la COVID-19
Traitements médicamenteux de la COVID-19 : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Traitements médicamenteux de la COVID-19 : Questions médicales les plus fréquentes",
"headline": "Traitements médicamenteux de la COVID-19 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Traitements médicamenteux de la COVID-19 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-17",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Traitements médicamenteux de la COVID-19"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Traitement médicamenteux",
"url": "https://questionsmedicales.fr/mesh/D004358",
"about": {
"@type": "MedicalCondition",
"name": "Traitement médicamenteux",
"code": {
"@type": "MedicalCode",
"code": "D004358",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Traitements médicamenteux de la COVID-19",
"alternateName": "COVID-19 Drug Treatment",
"code": {
"@type": "MedicalCode",
"code": "D000093485",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Didier Raoult",
"url": "https://questionsmedicales.fr/author/Didier%20Raoult",
"affiliation": {
"@type": "Organization",
"name": "Aix-Marseille Université, IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, 19-21 boulevard Jean Moulin, 13385 Marseille Cedex 05, France; IHU-Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385 Marseille Cedex 05, France."
}
},
{
"@type": "Person",
"name": "Francesco Potì",
"url": "https://questionsmedicales.fr/author/Francesco%20Pot%C3%AC",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine and Surgery - Unit of Neurosciences, University of Parma, Parma, Italy. francesco.poti@unipr.it."
}
},
{
"@type": "Person",
"name": "Taher Entezari-Maleki",
"url": "https://questionsmedicales.fr/author/Taher%20Entezari-Maleki",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. tentezari@gmail.com."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "David Brandariz-Nuñez",
"url": "https://questionsmedicales.fr/author/David%20Brandariz-Nu%C3%B1ez",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Farmacia, Hospital Quironsalud, Barcelona, España. Electronic address: vrandariz@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19.",
"datePublished": "2022-08-03",
"url": "https://questionsmedicales.fr/article/35955740",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23158606"
}
},
{
"@type": "ScholarlyArticle",
"name": "Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system.",
"datePublished": "2022-05-30",
"url": "https://questionsmedicales.fr/article/35654381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.micpath.2022.105608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ensitrelvir as a potential treatment for COVID-19.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36350029",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14656566.2022.2146493"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Approach to the Treatment of Children With COVID-19.",
"datePublished": "2022-07-13",
"url": "https://questionsmedicales.fr/article/35622429",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/INF.0000000000003576"
}
},
{
"@type": "ScholarlyArticle",
"name": "COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs.",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36362045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232113260"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Traitements médicamenteux de la COVID-19",
"item": "https://questionsmedicales.fr/mesh/D000093485"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Traitements médicamenteux de la COVID-19 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Traitements médicamenteux de la COVID-19",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Traitements médicamenteux de la COVID-19",
"description": "Les vaccins préviennent-ils la COVID-19 ?\nQuelles mesures de prévention sont recommandées ?\nLes traitements préventifs existent-ils ?\nLes masques chirurgicaux sont-ils efficaces ?\nLa vaccination est-elle obligatoire ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Traitements médicamenteux de la COVID-19",
"description": "Quels médicaments sont utilisés pour traiter la COVID-19 ?\nComment fonctionne le remdesivir ?\nLa dexaméthasone est-elle efficace pour tous les patients ?\nQuels sont les effets secondaires des traitements ?\nLes antibiotiques sont-ils utiles contre la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Traitements médicamenteux de la COVID-19",
"description": "Quelles sont les complications possibles de la COVID-19 ?\nComment la COVID-19 affecte-t-elle le cœur ?\nLes séquelles de la COVID-19 sont-elles fréquentes ?\nLa COVID-19 peut-elle affecter le système nerveux ?\nQuels sont les risques de thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Traitements médicamenteux de la COVID-19",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe sexe influence-t-il la gravité de la maladie ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'origine ethnique influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Les vaccins préviennent-ils la COVID-19 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins réduisent le risque d'infection et de formes graves de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles mesures de prévention sont recommandées ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le port du masque, la distanciation sociale et le lavage des mains sont essentiels."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs existent-ils ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme les anticorps monoclonaux peuvent être utilisés en prévention chez certains patients."
}
},
{
"@type": "Question",
"name": "Les masques chirurgicaux sont-ils efficaces ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent la transmission du virus en filtrant les gouttelettes respiratoires."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle obligatoire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend des réglementations locales, mais elle est fortement recommandée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter la COVID-19 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme le remdesivir et des corticostéroïdes comme la dexaméthasone sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment fonctionne le remdesivir ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le remdesivir inhibe la réplication du virus en bloquant l'ARN polymérase virale."
}
},
{
"@type": "Question",
"name": "La dexaméthasone est-elle efficace pour tous les patients ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace principalement chez les patients gravement malades nécessitant de l'oxygène."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des infections, des troubles gastro-intestinaux et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utiles contre la COVID-19 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne traitent pas les infections virales comme la COVID-19."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la COVID-19 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, le syndrome de détresse respiratoire et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Comment la COVID-19 affecte-t-elle le cœur ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des myocardites et des arythmies, augmentant le risque de complications cardiaques."
}
},
{
"@type": "Question",
"name": "Les séquelles de la COVID-19 sont-elles fréquentes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients présentent des symptômes persistants, appelés COVID long."
}
},
{
"@type": "Question",
"name": "La COVID-19 peut-elle affecter le système nerveux ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes neurologiques comme des maux de tête et des troubles de l'odorat peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de thrombose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La COVID-19 augmente le risque de thrombose veineuse et d'embolie pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les maladies chroniques et l'obésité."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles présentent un risque accru de formes graves de la COVID-19."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il la gravité de la maladie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent que les hommes peuvent avoir des formes plus graves que les femmes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou cardiovasculaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'origine ethnique influence-t-elle le risque ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que certaines ethnies peuvent être plus touchées par la COVID-19."
}
}
]
}
]
}
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral agent that causes Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when exacerbated, can have ...
The recent pandemic, Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has devastated humanity and is continuing to threaten us. Due to the hig...
First-generation therapeutics have improved clinical outcomes in patients infected with SARS-CoV-2. However, viral evolution has produced variants and subvariants capable of resisting many of these dr...
A corporate compound library screen identified ensitrelvir (formerly S-217622), a non-covalent, non-peptidic, orally bioavailable small-molecule protease inhibitor as a potential treatment for SARS-Co...
Ensitrelvir demonstrates strong...
There are limited data to guide treatment recommendations for children with acute, symptomatic coronavirus disease 2019 (COVID-19). This review outlines a proposed management approach for children bas...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces immune-mediated type 1 interferon (IFN-1) production, the pathophysiology of which involves sterile alpha motif and histidine-aspar...
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to societies and economies. Until now, effective therapeutics against COVID-19 are in high demand. Along with our im...
On 4 September, 2020, the US National Institutes of Health launched a new clinical trial, "A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic an...
The review traces the evolution of the section on the use of antibacterial drugs in the temporary guidelines of the Ministry of Health for the treatment of a new coronavirus infection. Diagnostic appr...
The optimal anticoagulation strategy for venous thromboembolism (VTE) prevention among COVID-19 patients, hospitalized or in the community setting, is still challenging and largely based on real-world...
We analyzed real-world data regarding the safety and effectiveness of anticoagulant treatment, both parenteral and oral, for VTE prevention or atrial fibrillation (AF)/VTE treatment among COVID-19 pat...
The efficacy of low-molecular-weight heparin (LMWH) doses for VTE prevention correlates with COVID-19 disease status. LMWH prophylactic dose may be useful in COVID-19 patients at the early stage of th...
Remdesivir is considered to be a specific drug for treating coronavirus disease 2019. This systematic review aims to evaluate the clinical efficacy and risk of remdesivir alone and in combination with...
The PubMed, Embase, SCIE, Cochrane Library, and American Clinical trial Center databases were searched up to 1 April 2022 to identify. Randomized controlled trials (RCTs) and observational studies com...
Ten RCTs and 32 observational studies were included in the analysis. Regarding the primary outcome, remdesivir use reduced mortality in patients with severe COVID-19 (RR = 0.57, 95% CI (0.48,0.68)) an...
The use of remdesivir can help to reduce the mortality of patients with severe COVID-19 and shorten the time to clinical improvement. There was no benefit of remdesivir combination therapy for other c...
PROSPERO registration number: CRD42022322859....